137 related articles for article (PubMed ID: 21930159)
21. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats.
Camarasa J; Marimón JM; Rodrigo T; Escubedo E; Pubill D
Eur J Pharmacol; 2008 Jul; 589(1-3):132-9. PubMed ID: 18582864
[TBL] [Abstract][Full Text] [Related]
22. 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus.
Mustafa S; Walker A; Bennett G; Wigmore PM
Eur J Neurosci; 2008 Jul; 28(2):323-30. PubMed ID: 18702703
[TBL] [Abstract][Full Text] [Related]
23. Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats.
Long JM; Lee GD; Kelley-Bell B; Spangler EL; Perez EJ; Longo DL; de Cabo R; Zou S; Rapp PR
Pharmacol Biochem Behav; 2011 Nov; 100(1):205-11. PubMed ID: 21875615
[TBL] [Abstract][Full Text] [Related]
24. Neurobiological changes by cytotoxic agents in mice.
Seigers R; Loos M; Van Tellingen O; Boogerd W; Smit AB; Schagen SB
Behav Brain Res; 2016 Feb; 299():19-26. PubMed ID: 26602283
[TBL] [Abstract][Full Text] [Related]
25. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
[TBL] [Abstract][Full Text] [Related]
26. The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory.
Fardell JE; Vardy J; Johnston IN
Life Sci; 2013 Oct; 93(17):596-604. PubMed ID: 23693082
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
Brown I; Ward HW
Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
[No Abstract] [Full Text] [Related]
28. Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer.
Qi M; Li JF; Xie YT; Lu AP; Lin BY; Ouyang T
Breast Cancer Res Treat; 2010 Aug; 123(1):197-202. PubMed ID: 20582466
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways.
Salas-Ramirez KY; Bagnall C; Frias L; Abdali SA; Ahles TA; Hubbard K
Behav Brain Res; 2015 Oct; 292():133-41. PubMed ID: 26099816
[TBL] [Abstract][Full Text] [Related]
30. The effect of doxorubicin or cyclophosphamide treatment on auditory brainstem response in mice.
Hennings M; Fremouw T
Exp Brain Res; 2022 Nov; 240(11):2907-2921. PubMed ID: 36123538
[TBL] [Abstract][Full Text] [Related]
31. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
34. Drug resistance in chemotherapy for breast cancer.
Saeki T; Tsuruo T; Sato W; Nishikawsa K
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of doxorubicin, cyclophosphamide, 5-fluorouracil, and cisplatin on cognitive dysfunction in rats: Delineating the role of inflammation of hippocampal neurons and hypothyroidism.
Alotayk LI; Aldubayan MA; Alenezi SK; Anwar MJ; Alhowail AH
Biomed Pharmacother; 2023 Sep; 165():115245. PubMed ID: 37523981
[TBL] [Abstract][Full Text] [Related]
36. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta).
Matalon ST; Ornoy A; Lishner M
Reprod Toxicol; 2004; 18(2):219-30. PubMed ID: 15019720
[No Abstract] [Full Text] [Related]
37. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
38. Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats.
Iarkov A; Appunn D; Echeverria V
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1033-1039. PubMed ID: 27709283
[TBL] [Abstract][Full Text] [Related]
39. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
40. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
